Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 46 (RPL23AP46)

Target
RPL23AP46
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L23a pseudogene 46 (RPL23AP46) is one of many processed pseudogenes in the human genome that are related to the functional *RPL23A* gene, which encodes a component of the large (60S) ribosomal subunit. Pseudogenes like RPL23AP46 are non-coding sequences that originate from functional genes but are no longer translated into functional proteins due to mutations or other genomic changes. As a pseudogene, RPL23AP46 does not encode an active protein and is not involved in ribosome biogenesis or function. Most ribosomal protein pseudogenes, including this one, are believed to have little or no direct biological function; however, in rare cases, some pseudogenes have been reported to regulate gene expression or participate in disease processes, but there are no specific data linking RPL23AP46 to any disease or therapeutic context. Context about Related Genes: - The active gene *RPL23A* encodes a protein important in ribosome structure and function. It has been studied as a potential autoimmune target and has roles in certain cancers, but these properties do not extend to the processed pseudogenes like RPL23AP46. - Of the large family of ribosomal protein pseudogenes, some other members have been analyzed for their correlation with prognosis in cancer, but RPL23AP46 has no described biological or clinical significance in available scientific literature. Summary: RPL23AP46 ("ribosomal protein L23a pseudogene 46") is an accurately named, transcriptionally inactive pseudogene of the ribosomal protein L23a family, with no therapeutic, biological, or clinical significance as a molecular target.

Other names
RPL23AP46ribosomal protein L23a pseudogene 46
02

Biological functions

Possibly involved in transcriptional noise or regulation as a pseudogene; no direct biological function proven for this pseudogene
03

Disease associations

Other (No established disease role for this specific pseudogene; see below for context on related pseudogenes)

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 46 (RPL23AP46).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 46 (RPL23AP46).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call